Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce

Abstract Background Although it has been shown that allergen immunotherapy (AIT) is well‐tolerated in children, systematic and prospective surveillance of AIT safety in real life settings is needed. Methods The multinational Allergen Immunotherapy Adverse Events Registry (ADER) was designed to addre...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Julijana Asllani, Dimitrios Mitsias, George Konstantinou, Eris Mesonjesi, Fatmira Xhixha, Esmeralda Shehu, George Christoff, Katia Noleva, Michael Makris, Xenofon Aggelidis, Mirjana Turkalj, Erceg Damir, Ioana Agache, Vesna Tomic‐Spiric, Rajica Stosovic, Zeynep Misirligil, Mitja Kosnik, Todor A. Popov, Moises Calderon, Nikolaos G. Papadopoulos, ADER study group
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-06-01
Edice:	Clinical and Translational Allergy
Témata:	adverse events allergen immunotherapy real‐life settings risk factors
On-line přístup:	https://doi.org/10.1002/clt2.12250
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!